![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 213/74 | (2006.01) |
A61K 31/44 | (2006.01) | ||
A61K 31/50 | (2006.01) | ||
A61K 31/53 | (2006.01) | ||
A61K 31/421 | (2006.01) | ||
A61K 31/426 | (2006.01) | ||
A61K 31/4427 | (2006.01) | ||
A61K 31/4965 | (2006.01) | ||
A61K 31/497 | (2006.01) | ||
A61K 31/501 | (2006.01) | ||
A61K 31/505 | (2006.01) | ||
C07D 213/73 | (2006.01) | ||
C07D 213/76 | (2006.01) |
(11) | Number of the document | 2402317 |
(13) | Kind of document | T |
(96) | European patent application number | 11158216.9 |
Date of filing the European patent application | 2007-03-28 | |
(97) | Date of publication of the European application | 2012-01-04 |
(45) | Date of publication and mention of the grant of the patent | 2013-07-03 |
(46) | Date of publication of the claims translation | 2013-11-25 |
(30) | Number | Date | Country code |
787859 P | 2006-03-31 | US |
(72) |
Serrano-Wu, Michael H, US
Kwak, Young-Shin, US
Liu, Wenming, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | DGAT inhibitorius |
DGAT inhibitor |
Payment date | Validity (years) | Amount | |
2018-03-01 | 12 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2019-03-28 |